Log in
Enquire now
Nitrase Therapeutics

Nitrase Therapeutics

Nitrase Therapeutics is a Brisbane, California-based company offering a biopharmaceutical platform, Nitrome, designed to offer therapies against a broad variety of diseases.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
Also Known As
NItrome Biosciences
CEO
‌
Irene Griswold-Prenner
0
Company Operating Status
Active
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...sciences
Founder
‌
Irene Griswold-Prenner
Industry
Healthcare
Healthcare
Medicine
Medicine
‌
Neurobiology
Biotechnology
Biotechnology
Chemistry
Chemistry
Engineering
Engineering
Enzyme
Enzyme
Biomedical engineering
Biomedical engineering
Investors
Bristol-Myers Squibb
Bristol-Myers Squibb
AbbVie Ventures
AbbVie Ventures
Alexandria Venture Investments
Alexandria Venture Investments
Dementia Discovery Fund
Dementia Discovery Fund
Mission Bay Capital
Mission Bay Capital
Latest Funding Round Date
April 22, 2020
2021
Latest Funding Round Amount (USD)
45,000,000
38,000,000
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/nitrase-therapeutics
Location
San Francisco
San Francisco
Patents Assigned (Count)
1
Pitchbook URL
pitchbook.com/profiles...230974-48
Total Funding Amount (USD)
38,000,000
83,000,000
Official Website
nitromebiosciences.com
nitrasetx.com

Find more companies like Nitrase Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.